Press release
Competitive Landscape: Leading Companies and New Entrants in the Ribonucleic Acid Interference (RNAi) Technology Market
Ribonucleic Acid Interference RNAi Technology
Projected Market Value Growth in RNAi Technology
The RNAi technology market is expected to experience significant expansion, reaching a value of $7.96 billion by 2029. This growth corresponds to a compound annual growth rate (CAGR) of 15.7%. Several elements contribute to this upward trend, including a surge in clinical trials and patient enrollments, increased collaborations such as partnerships, mergers, and licensing deals, as well as growing healthcare expenditures focused on specialty and precision medicines. Additionally, the rising demand for personalized therapies and the increasing prevalence of oncology and chronic liver diseases are important growth drivers. Noteworthy trends anticipated during this period include innovations in lipid nanoparticle delivery systems, advancements in n-acetylgalactosamine conjugate targeting for the liver, optimization of self-delivering small interfering RNA platforms, AI-assisted design to reduce off-target effects, and developments in exosome-mediated and cell-penetrating peptide delivery techniques.
Download a free sample of the ribonucleic acid interference (rnai) technology market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30371&type=smp
Top Companies Leading the RNAi Technology Market
The RNAi technology sector features several prominent companies spearheading innovation and commercialization efforts. These key players include F. Hoffmann-La Roche AG, Merck KGaA, Novartis AG, Thermo Fisher Scientific Inc., Danaher Corporation, Revvity Inc., QIAGEN N.V., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., GenScript Biotech Corporation, Promega Corporation, Arrowhead Pharmaceuticals Inc., Silence Therapeutics plc, Creative Biolabs Inc., Bioneer Corporation, Genevant Sciences Ltd., Gradalis Inc., Altogen Labs LLC, Sirnaomics Inc., and Altogen Biosystems Inc. Each company contributes uniquely to advancing RNAi technologies across therapeutic and research applications.
Significant Acquisition in the RNAi Space
In a strategic move to enhance its capabilities in RNAi therapeutics, Novartis AG, headquartered in Switzerland, acquired DTx Pharma Inc. in July 2023 for an undisclosed sum. This acquisition aims to bolster Novartis's portfolio in neuromuscular diseases by leveraging DTx Pharma's FALCON delivery platform. DTx Pharma, a biotechnology firm based in the United States and operating at the preclinical stage, specializes in RNAi technology focused on developing novel RNAi-based treatments.
View the full ribonucleic acid interference (rnai) technology market report:
https://www.thebusinessresearchcompany.com/report/global-ribonucleic-acid-interference-rnai-technology-market-report
Emerging Trends Shaping RNAi Technology Development
Many leading companies are prioritizing platform integration to streamline the research, development, and commercialization stages of RNAi therapeutics. This approach involves securing strategic funding and support to maintain a sustainable pipeline that addresses multiple disease areas. Investments from venture capitalists, industry partners, and other stakeholders play a critical role in accelerating these efforts.
For example, in October 2024, City Therapeutics Inc., a US biopharmaceutical company, secured $135 million in Series A financing led by ARCH Venture Partners, alongside participation from other prominent life sciences investors. This funding will help advance RNAi-based medicines by utilizing City Therapeutics' proprietary lipid nanoparticle delivery platform, designed specifically to target tissues beyond the liver with high precision. This innovation addresses a long-standing limitation in RNAi technology, enabling the development of treatments for a broader range of genetic disorders.
Breakdown of Key Product and Application Segments in RNAi Technology
The RNAi technology market can be segmented into several categories as follows:
1) Product Types:
- Micro Ribonucleic Acid (miRNA)
- Small Interfering Ribonucleic Acid (siRNA)
- Other related products
2) Delivery Methods:
- Viral Vectors
- Nanoparticles
- Chemical Modifications
- Physical Methods
3) Applications:
- Therapeutics
- Drug Discovery
- Agriculture
- Diagnostics
4) End-Users:
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutions
- Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
Further subdivisions specify:
- miRNA products such as mimics, inhibitors, expression vectors, and profiling kits.
- siRNA products including synthetic duplexes, dicer substrate molecules, self-delivering conjugates, and n-acetylgalactosamine conjugates.
- Other products like short hairpin RNA expression constructs, RNAi screening libraries, RNAi transfection reagents, and research kits for both miRNA and siRNA.
This detailed segmentation highlights the diverse and complex nature of the RNAi technology market, reflecting its wide-ranging applications and the innovative delivery mechanisms driving its future growth.
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Competitive Landscape: Leading Companies and New Entrants in the Ribonucleic Acid Interference (RNAi) Technology Market here
News-ID: 4309231 • Views: …
More Releases from The Business Research Company
Future Perspectives: Key Trends Shaping the Ready-To-Use Antibodies Market Until …
The ready-to-use antibodies market is on a promising trajectory, showing potential for significant growth fueled by innovations in biotechnology and a growing emphasis on personalized healthcare. As research and development continue to evolve, this sector is expected to see considerable expansion and technological advancements in the coming years.
Ready-To-Use Antibodies Market Size and Growth Outlook Through 2029
The ready-to-use antibodies market is predicted to expand steadily, reaching a valuation of $7.75 billion…
Leading Companies Consolidate Their Roles in the Precision Psychiatry Market
The precision psychiatry sector is gaining considerable attention as advancements in technology and personalized medicine continue to transform mental health care. Positioned to revolutionize psychiatric treatment, this market is on track for significant expansion, driven by innovative tools and collaborative efforts across the healthcare landscape. Here's a detailed look at its growth prospects, major players, emerging trends, and market segmentation.
Projected Market Size and Growth of the Precision Psychiatry Market
The precision…
Worldwide Market Insights: The Rapid Evolution of the Phone Tripod With Remote S …
The phone tripod with remote market is on the brink of significant expansion, driven by technological advances and shifting consumer demands. As photography and content creation continue to evolve, the need for versatile and user-friendly accessories is becoming more pronounced. Let's explore the market's size, major players, emerging trends, and the segmentation shaping its landscape.
Projected Market Growth of the Phone Tripod With Remote Market
The phone tripod with remote market is…
Overview of the Paid Membership Program Platform Market: Structure, Emerging Tre …
The paid membership program platform market is gaining significant traction globally, driven by evolving technologies and shifting consumer preferences. As businesses and organizations increasingly adopt subscription-based models, these platforms are becoming essential tools for managing memberships, enhancing engagement, and fostering community connections. Let's explore the market size, key players, emerging trends, and segmentation to understand where this industry is headed.
Forecasted Expansion of the Paid Membership Program Platform Market by 2029
The…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
